Qingdao Haier Biomedical Co Ltd
Qingdao Haier Biomedical Co.,Ltd engages in the research and development, manufacture, marketing, and sale of low temperature storage equipment for biomedical samples in China and internationally. The company offers ULT freezers, pharmacy refrigerators, freezers, automatic storage solutions, cryogenics, active temperature controlled RKN containers, transport coolers, and RTMD products; and CO2 in… Read more
Qingdao Haier Biomedical Co Ltd (688139) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of June 2023: 0.002x
Based on the latest financial reports, Qingdao Haier Biomedical Co Ltd (688139) has a cash flow conversion efficiency ratio of 0.002x as of June 2023.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥7.33 Million) by net assets (CN¥4.34 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Qingdao Haier Biomedical Co Ltd - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Qingdao Haier Biomedical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Qingdao Haier Biomedical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Qingdao Haier Biomedical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Grupo Simec S.A.B. de C.V
MX:SIMECB
|
0.006x |
|
Zhejiang Hailide New Material Co Ltd
SHE:002206
|
0.069x |
|
Banco do Estado do Rio Grande do Sul S.A
SA:BRSR3
|
0.283x |
|
Ningbo PIA Automation Holding Corp. A
SHG:688306
|
N/A |
|
United International Enterprises Ltd.
LSE:0KGQ
|
N/A |
|
Vestjysk Bank A/S
CO:VJBA
|
0.003x |
|
Genertec Universal Medical Group Company Limited
F:5UM
|
-0.073x |
|
Eris Lifesciences Limited
NSE:ERIS
|
0.068x |
Annual Cash Flow Conversion Efficiency for Qingdao Haier Biomedical Co Ltd (2016–2024)
The table below shows the annual cash flow conversion efficiency of Qingdao Haier Biomedical Co Ltd from 2016 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥4.62 Billion | CN¥291.67 Million | 0.063x | +12.50% |
| 2023-12-31 | CN¥4.44 Billion | CN¥249.26 Million | 0.056x | -63.17% |
| 2022-12-31 | CN¥4.15 Billion | CN¥632.43 Million | 0.152x | -12.28% |
| 2021-12-31 | CN¥3.64 Billion | CN¥632.43 Million | 0.174x | -30.53% |
| 2020-12-31 | CN¥2.78 Billion | CN¥696.62 Million | 0.250x | +119.32% |
| 2019-12-31 | CN¥2.46 Billion | CN¥280.49 Million | 0.114x | -14.74% |
| 2018-12-31 | CN¥1.11 Billion | CN¥149.00 Million | 0.134x | -44.55% |
| 2017-12-31 | CN¥614.76 Million | CN¥148.32 Million | 0.241x | -20.99% |
| 2016-12-31 | CN¥722.81 Million | CN¥220.72 Million | 0.305x | -- |